Floatz logo

Inno-206

Mediastinal Neoplasm

City of Hope Medical CenterPhase 4 / ApprovedActive
BB
71/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
56/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Mediastinal Neoplasm cohort.

Asset / SponsorPhaseRating
Raltitrexed
City of Hope Medical Center
Phase 2CCC
Idarubicine
City of Hope Medical Center
Phase 2CCC
MITOMYCIN C
City of Hope Medical Center
Phase 2CCC
Ethiodized Oil
City of Hope Medical Center
Phase 2CCC
Eloxatin
City of Hope Medical Center
Phase 2CCC

Same molecule, other indications

Inno-206 is also rated in:

adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
77 / 100
View asset →
plasma cell myelomaDormant
BBB
Indicative ·
77 / 100
View asset →
Recurrent Adult Acute Lymphoblastic LeukemiaDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →